SE9702083D0 - Farmaceutisk beredning för bekämpning av patogena tarmbakterier - Google Patents

Farmaceutisk beredning för bekämpning av patogena tarmbakterier

Info

Publication number
SE9702083D0
SE9702083D0 SE9702083A SE9702083A SE9702083D0 SE 9702083 D0 SE9702083 D0 SE 9702083D0 SE 9702083 A SE9702083 A SE 9702083A SE 9702083 A SE9702083 A SE 9702083A SE 9702083 D0 SE9702083 D0 SE 9702083D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
intestinal bacteria
controlling pathogenic
pathogenic intestinal
preparation
Prior art date
Application number
SE9702083A
Other languages
English (en)
Other versions
SE9702083L (sv
SE511524C2 (sv
Inventor
Haakansson Eva Grahn
Stellan Haakansson
Original Assignee
Essum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essum Ab filed Critical Essum Ab
Priority to SE9702083A priority Critical patent/SE511524C2/sv
Publication of SE9702083D0 publication Critical patent/SE9702083D0/sv
Priority to PCT/SE1998/001041 priority patent/WO1998055131A1/en
Priority to CA002291623A priority patent/CA2291623A1/en
Priority to AT98928734T priority patent/ATE304366T1/de
Priority to DE69831578T priority patent/DE69831578T2/de
Priority to EP98928734A priority patent/EP1005353B1/en
Priority to DK98928734T priority patent/DK1005353T3/da
Priority to ES98928734T priority patent/ES2245801T3/es
Priority to JP50225399A priority patent/JP4350170B2/ja
Priority to AU80460/98A priority patent/AU726217B2/en
Priority to CNB988070170A priority patent/CN1153575C/zh
Publication of SE9702083L publication Critical patent/SE9702083L/sv
Publication of SE511524C2 publication Critical patent/SE511524C2/sv
Priority to NO19995794A priority patent/NO326122B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SE9702083A 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier SE511524C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
CNB988070170A CN1153575C (zh) 1997-06-02 1998-06-02 包含鼠李糖乳杆菌的药物制剂
DK98928734T DK1005353T3 (da) 1997-06-02 1998-06-02 Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
CA002291623A CA2291623A1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
AT98928734T ATE304366T1 (de) 1997-06-02 1998-06-02 Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
DE69831578T DE69831578T2 (de) 1997-06-02 1998-06-02 Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
EP98928734A EP1005353B1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
PCT/SE1998/001041 WO1998055131A1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
ES98928734T ES2245801T3 (es) 1997-06-02 1998-06-02 Preparacion farmaceutica que comprende lactobacillus casei rhamnosus.
JP50225399A JP4350170B2 (ja) 1997-06-02 1998-06-02 ラクトバチルス・カセイ・ラムノススを含む薬学的調製物
AU80460/98A AU726217B2 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
NO19995794A NO326122B1 (no) 1997-06-02 1999-11-26 Farmasoytisk preparat inneholdende "Lactobacillus casei rhamnosus"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier

Publications (3)

Publication Number Publication Date
SE9702083D0 true SE9702083D0 (sv) 1997-06-02
SE9702083L SE9702083L (sv) 1998-12-03
SE511524C2 SE511524C2 (sv) 1999-10-11

Family

ID=20407203

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier

Country Status (12)

Country Link
EP (1) EP1005353B1 (sv)
JP (1) JP4350170B2 (sv)
CN (1) CN1153575C (sv)
AT (1) ATE304366T1 (sv)
AU (1) AU726217B2 (sv)
CA (1) CA2291623A1 (sv)
DE (1) DE69831578T2 (sv)
DK (1) DK1005353T3 (sv)
ES (1) ES2245801T3 (sv)
NO (1) NO326122B1 (sv)
SE (1) SE511524C2 (sv)
WO (1) WO1998055131A1 (sv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
WO2001052667A2 (en) * 2000-01-18 2001-07-26 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
BR0006628A (pt) * 2000-12-07 2004-06-22 Sanab Saneamento Ambiental E B Sistema anaeróbico de tratamento de lixo urbano, resìduos agro-industrias e biomassa
KR100424790B1 (ko) * 2000-12-08 2004-03-30 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
AU7675601A (en) * 2000-12-08 2002-06-18 Pl Bio Co Ltd Lactic acid bacteria with inhibiting activities on (helicobacter pylori)
KR100449597B1 (ko) * 2000-12-08 2004-09-18 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
WO2002045727A1 (en) * 2000-12-08 2002-06-13 Plbio Co., Ltd. Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
IL156490A0 (en) 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
JPWO2002055092A1 (ja) * 2001-01-16 2004-05-13 天藤製薬株式会社 消化管疾患の予防及び／又は治療剤
US8895310B2 (en) * 2002-12-02 2014-11-25 Basf Se L-rhamnose-inducible expression systems
WO2005085287A1 (en) 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
PL1996696T3 (pl) * 2006-03-17 2017-08-31 Probi Aktiebolag Termostabilne szczepy Lactobacillus
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
CN101173228B (zh) * 2006-11-01 2011-08-17 信谊药厂 新的乳酸杆菌菌株、药物组合物及其用途、以及制造方法
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
PL2349295T3 (pl) * 2008-11-17 2017-06-30 Winclove Holding B.V. Preparat farmaceutyczny zawierający kombinację szczepów paciorkowców i szczepów lactobacillus
BRPI0922296A2 (pt) * 2008-12-05 2015-08-11 Nestec Sa Composições para o uso em recém-nascidos com baixo peso no nascimento.
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2604123A1 (en) 2011-12-15 2013-06-19 Friesland Brands B.V. Method and nutritional compositions for the treatment of diarrhea.
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
EP2923704B1 (en) 2012-11-16 2024-03-20 Asahi Group Holdings, Ltd. Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR102523805B1 (ko) 2014-12-23 2023-04-20 4디 파마 리서치 리미티드 면역 조정
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
DK3206700T3 (da) 2015-06-15 2019-08-05 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PT3240554T (pt) 2015-06-15 2019-11-04 4D Pharma Res Ltd Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PT3307288T (pt) 2015-06-15 2019-10-17 4D Pharma Res Ltd Composições compreendendo estirpes bacterianas
KR101914245B1 (ko) 2015-11-20 2018-11-02 4디 파마 리서치 리미티드 박테리아성 균주를 함유한 조성물
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA42560B1 (fr) 2016-03-04 2019-07-31 4D Pharma Plc Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
TW201907928A (zh) 2017-05-22 2019-03-01 英商4D製藥研究有限公司 包含細菌品系之組成物
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA49425A (fr) 2017-06-14 2020-04-22 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2841902T3 (es) 2017-06-14 2021-07-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
CN109182166B (zh) * 2018-08-27 2021-08-20 南昌大学 一株具有缓解便秘功效的鼠李糖乳杆菌及其应用
CN110295130A (zh) * 2019-07-29 2019-10-01 诺佰克（武汉）生物科技有限公司 一株鼠李糖乳杆菌及其应用
CN113088470A (zh) * 2021-04-14 2021-07-09 广东医科大学 一株鼠李糖乳杆菌L.rB16及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) * 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen

Also Published As

Publication number Publication date
EP1005353A1 (en) 2000-06-07
DK1005353T3 (da) 2005-10-03
JP4350170B2 (ja) 2009-10-21
CN1153575C (zh) 2004-06-16
JP2002507200A (ja) 2002-03-05
ES2245801T3 (es) 2006-01-16
DE69831578D1 (de) 2005-10-20
ATE304366T1 (de) 2005-09-15
DE69831578T2 (de) 2006-04-27
SE9702083L (sv) 1998-12-03
SE511524C2 (sv) 1999-10-11
CA2291623A1 (en) 1998-12-10
EP1005353B1 (en) 2005-09-14
CN1272791A (zh) 2000-11-08
AU8046098A (en) 1998-12-21
NO995794L (no) 2000-01-31
NO995794D0 (no) 1999-11-26
AU726217B2 (en) 2000-11-02
WO1998055131A1 (en) 1998-12-10
NO326122B1 (no) 2008-09-29

Similar Documents

Publication Publication Date Title
SE9702083D0 (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
BR9808520A (pt) Medicamento vaginal de lactobacilos
DK0506817T3 (da) Farmaceutisk præparat til kontrol med patogene intestinale bakterier
DE69224814D1 (de) Den darm kolonisierende laktobacillen
NO975136D0 (no) Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin
ATE299177T1 (de) Milchsäurebakterien und ihre anwendung zur herstellung von hypercholesterolemische aktive produkte
TW365538B (en) Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans
EP0949330A3 (en) Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli cultures
RU2072692C1 (ru) Штамм бактерий lactobacillus helveticus, обладающий способностью снижать уровень холестерина в крови и используемый для получения препаратов и продуктов питания для профилактики и лечения гиперхолестеринемий
RU95103470A (ru) Средство для раннего лечения радиационных и комбинированных радиационно-термических поражений
RU99125560A (ru) Способ контроля антагонистической активности препаратов для лечения и профилактики дисбактериозов
RU92015133A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
RU2003112420A (ru) Биопрепарат лечебно-профилактического действия при эндометритах животных
RU92015134A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris syreptococcusthermophilus streptococcus bovis) 3844 для активации прорастания семян
RU2000117915A (ru) Штаммы микроорганизмов bifidobacterium longum в-12, lactobacillus plantarum р-19, enterococcus faecium е-18, bacillus subtilus в-26, применяемые для получения пробиотика бифицина
MD669G2 (ro) Tulpină a bacteriilor Lactobacillus acidophilus utilizată la prepararea eubioticelor
GEP20033132B (en) Bacteriological Preparations
ES2169675A1 (es) Producto con propiedades antiinflamatorias para el colon humano.
RU92015321A (ru) Консорциум бактерий (streptococcus thermophilus, streptococcus fovis, lactobacillus salivarius var, salicinicus, lactobacillus salivarius var.salivarius, lactobacillus acidobhilus) 5842 для активации почвенной микрофлоры

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed